Previous 10 | Next 10 |
Nasdaq Listing Qualifications department notified Sesen Bio ( NASDAQ: SESN ) that it has been granted a second 180-day grace period, or until Jan.23, 2023 for regaining compliance with the minimum bid price requirement. In January, the company had received its no...
The shares of cancer-focused biotech Sesen Bio ( NASDAQ: SESN ) lost 29% on Monday after the company announced its decision to pause further development of its lead asset Vicineum in the U.S. Sesen ( SESN ) noted that after discussions with the FDA, the company rea...
The shares of cancer-focused biotech Sesen Bio ( NASDAQ: SESN ) traded lower in the pre-market Monday after the company announced its decision to pause the further development of its lead asset Vicineum in the U.S. Sesen ( SESN ) noted that after discussions with the F...
Company intends to seek a partner for further development of Vicineum Sesen Bio continues to focus on the assessment of potential strategic alternatives Sesen Bio (Nasdaq: SESN ) today announced that it has made the strategic decision to voluntarily pause fur...
3 Industries That Penny Stocks Investors Are Watching If you’re looking for industries to find penny stocks to buy, there are a few that penny stock investors are watching right now. While there are dozens of industries for investors to choose from, it all comes down to knowing y...
Sesen Bio (NASDAQ:SESN) +18.2% stated Friday that it doesn't plan to effect a reverse stock split of its shares and hence has removed the proposal for split from the agenda of its annual shareholders' meeting to be held on June 22, 2022. The clinical-stage biotech company said ...
You can’t argue that biotech stocks were hit hard during the 2022 stock market crash. But that doesn’t mean opportunity was utterly stifled. Depending on your outlook and investment style, volatility has become a considerable asset to some. You know what I’m talking abo...
Penny stocks are defined as shares of companies trading below $5. That may be the standard but it down not nearly explain the entire landscape of “cheap” stocks. Traders hunt for these lower-priced equities thanks to their inherent potential for quick gains. While Apple or Net...
FTSE Russell has released a preliminary lists of companies set to join or leave the Russell Microcap Index as part of its 2022 annual reconstitution. Notable health care additions include: Inovio Pharma (INO), Bionano Genomics (BNGO), Sorrento Therapeutics (SRNE), Ocu...
SESN is a clinical-stage biopharma company working on the treatment of patients with BCG-unresponsive non-muscle invasive bladder cancer (NMIBC). FDA declined to approve the company's flagship drug Vicineum. Subsequently, management has started a strategic review. SESN trades ...
News, Short Squeeze, Breakout and More Instantly...
Sesen Bio Inc. Company Name:
SESN Stock Symbol:
NASDAQ Market:
Declares Special Dividend in the Aggregate of $75 Million Approximately 88% Voted in Favor of the Merger at the Special Meeting Merger on Track to Close on March 7, 2023 Sesen Bio, Inc. (Nasdaq: SESN) (“Sesen Bio” or the “Company”), today anno...
Sesen Bio Board Believes the Pending Merger with Carisma is the Most Value-Maximizing Option for Stockholders Reiterates Support from Several of Sesen Bio’s Largest Stockholders and Two Leading Independent Proxy Advisors Sesen Bio Board Unanimously Recommends All St...
Positive Recommendations Underscore that Carisma Merger Maximizes Value for Sesen Bio Stockholders Sesen Bio Board Unanimously Recommends All Stockholders to Follow ISS and Glass Lewis’s Recommendations to Vote “FOR” Value Maximizing Merger on WHITE ...